An Illinois woman recently filed a new Zantac lawsuit in the U.S. District Court for the District of New Jersey. She claims that after taking the antacid drug for years, she developed cancer, which she believes was caused by the medication. Multiple manufacturers, including Sanofi,…
The U.S. Food and Drug Administration (FDA) recently cited Dr. Reddy’s plant in India for failing to conduct adequate testing and investigating to maintain the safety of their drug products. Such failures may be tied to the contamination of certain high blood pressure and heart…
Thirteen plaintiffs collectively filed a new class-action Zantac lawsuit in the U.S. District Court for the District of Ohio. The plaintiffs seek to represent all other U.S. Zantac users who may now be at risk for developing cancer, based on the FDA’s warning that Zantac…
In March 2019, the U.S. Food and Drug Administration (FDA) issued a letter to health care providers warning them of the increasing number of adverse events associated with surgical staplers and staples for internal use. The FDA analyzed the medical reports concerning these devices and…
In March 2019, the Food and Drug Administration (FDA) issued a letter to healthcare providers warning them of an increasing number of adverse events associated with surgical staples. The agency analyzed reports received between January 1, 2011, and March 31, 2018, and found 41,000 individual…
In September 2019, a jury in New Brunswick, New Jersey, ordered Johnson & Johnson (J&J) to pay $37.2 million in a baby powder lawsuit. Four plaintiffs had filed the lawsuit, claiming J&J should be held liable for failing to warn that their talc-based products could be contaminated with cancer-causing…
On October 2, 2019, the U.S Judicial Panel on Multidistrict Litigation (JPML) ordered that all federally filed JUUL lawsuits be consolidated into one court in the U.S. District Court for the Northern District of California for pre-trial proceedings. District Judge William H. Orrick was assigned…
Panel on Multidistrict Litigation (JPML) heard arguments to consider consolidating all federally filed Zantac lawsuits before one court. Both plaintiffs and defendants agreed that consolidation was prudent given the shared questions of fact, but they disagreed on the preferred location for the MDL. Following the…
On November 4, 2019, plaintiffs involved in Zantac lawsuits filed a motion with the U.S. Judicial Panel on Multidistrict Litigation (JPML) to consolidate all federally filed Zantac lawsuits into one federal court for more efficient pre-trial proceedings. Consolidation will help preserve resources and provide for…
As JUUL Labs struggles under increasing pressure and investigations over its marketing of its e-cigarettes to minors, one of its major investors—Altria—now faces a new class-action lawsuit filed by plaintiffs who claim the company misled its investors when buying a stake in the manufacturing company.…